Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-18

Clinical Trial Update: Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy [Phase 2]

View source ↗

Summary

Phase II study evaluating curcumin versus placebo in chemotherapy-treated breast cancer patients undergoing radiotherapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Andrew H Miller | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-09-18